Trial

Zacks Small Cap Research – CVKD: Collaborating with Abbott for Pivotal Phase 3 Trial… – Go Health Pro

by

By David Bautz, PhD NASDAQ:CVKD READ THE FULL CVKD RESEARCH REPORT Business Update Collaboration Agreement with Abbott for Phase 3 TECH-LVAD Trial On March 4, 2025, Cadrenal Therapeutics, Inc. (NASDAQ:CVKD) announced a collaboration agreement with Abbott for the Phase 3 TECarfarin Anticoagulation and Hemocompatibility with Left Ventricular Assist Devices (TECH-LVAD) trial. In August 2024, Cadrenal … Read more

Trial Begins in Texas Pipeline Company’s Lawsuit Over Dakota Access Pipeline Protests – Go Health Pro

by
Trial Begins in Texas Pipeline Company’s Lawsuit Over Dakota Access Pipeline Protests – Go Health Pro

An attorney for a Texas pipeline company said Wednesday at trial that he will prove various Greenpeace entities coordinated delays and disruptions of a controversial oil pipeline’s construction in North Dakota, and defamed the company to its lenders. Attorneys for the Greenpeace defendants told a jury there is no evidence to back up the claims … Read more

El trial despide con honores a Adam Raga, el eterno antagonista de Toni Bou | Deportes – Go Health Pro

by
El trial despide con honores a Adam Raga, el eterno antagonista de Toni Bou | Deportes – Go Health Pro

A Adam Raga Sans (Ulldecona, Tarragona; 42 años) se le hará extraño dejar de una vez por todas la competición. Aunque es una decisión meditada desde el pasado verano, la intención de despedirse en casa, ante el público de la 48º edición del Trial Indoor de Barcelona, le ha obligado a mantenerse en plena forma … Read more

Zacks Small Cap Research – AEMD Treats First Patient in Australian Safety, Feasibility & Dose-Finding Clinical Trial of Hemopurifier – Go Health Pro

by
Zacks Small Cap Research – AEMD Treats First Patient in Australian Safety, Feasibility & Dose-Finding Clinical Trial of Hemopurifier – Go Health Pro

By M. Marin NASDAQ:AEMD Aethlon Medical (NASDAQ:AEMD) announced that the first patient in its Australian safety, feasibility and dose-finding clinical trial has been treated with the Hemopurifier. The trial is designed for patients with solid tumors who have stable or progressive disease during anti-PD-1 monotherapy treatment. In other words, the trial is evaluating the Hemopurifier … Read more

Zacks Small Cap Research – MTVA: Compelling Data for DA-1241 in Phase 2a MASH Trial… – Go Health Pro

by
Zacks Small Cap Research – MTVA: Compelling Data for DA-1241 in Phase 2a MASH Trial… – Go Health Pro

By David Bautz, PhD NASDAQ:MTVA READ THE FULL MTVA RESEARCH REPORT Business Update Compelling Results for DA-1241 in Phase 2a MASH Trial On December 18, 2024, MetaVia Inc. (NASDAQ:MTVA) announced positive topline results from the 16-week Phase 2a clinical trial of DA-1241 in patients with presumed metabolic dysfunction-associated steatohepatitis (MASH). The trial had two parts: … Read more

x